Edwards Lifesciences Corp.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US28176E1082
USD
85.76
-0.22 (-0.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DexCom, Inc.
IDEXX Laboratories, Inc.
Intuitive Surgical, Inc.
Edwards Lifesciences Corp.
Agilent Technologies, Inc.
Medtronic Plc
Thermo Fisher Scientific, Inc.
Stryker Corp.
Danaher Corp.
Abbott Laboratories
Becton, Dickinson & Co.

Why is Edwards Lifesciences Corp. ?

1
High Management Efficiency with a high ROE of 22.80%
2
Company has a low Debt to Equity ratio (avg) at times
3
Flat results in Jun 25
  • OPERATING CASH FLOW(Y) Lowest at USD 794.9 MM
  • ROCE(HY) Lowest at 15.71%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 6.55 times
4
With ROE of 15.23%, it has a fair valuation with a 4.62 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 14.13%, its profits have fallen by -0.5% ; the PEG ratio of the company is 20.6
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Edwards Lifesciences Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Edwards Lifesciences Corp. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Edwards Lifesciences Corp.
13.63%
-0.09
23.89%
S&P 500
22.93%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
6.70%
EBIT Growth (5y)
4.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.60
Tax Ratio
10.93%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.32%
ROCE (avg)
29.61%
ROE (avg)
22.80%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
4.59
EV to EBIT
26.88
EV to EBITDA
24.53
EV to Capital Employed
6.51
EV to Sales
7.22
PEG Ratio
25.48
Dividend Yield
NA
ROCE (Latest)
24.21%
ROE (Latest)
13.99%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 1,358.6 MM

NET SALES(Q)

Highest at USD 1,648.6 MM

RAW MATERIAL COST(Y)

Fallen by -0.3% (YoY

CASH AND EQV(HY)

Highest at USD 7,899.3 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.24 times

DEBTORS TURNOVER RATIO(HY)

Highest at 7.31 times

OPERATING PROFIT(Q)

Highest at USD 558.1 MM

OPERATING PROFIT MARGIN(Q)

Highest at 33.85 %

PRE-TAX PROFIT(Q)

Highest at USD 555.1 MM

NET PROFIT(Q)

Highest at USD 460.41 MM

EPS(Q)

Highest at USD 0.66

-3What is not working for the Company
ROCE(HY)

Lowest at 10.52%

Here's what is working for Edwards Lifesciences Corp.

Operating Cash Flow
Highest at USD 1,358.6 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 1,648.6 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Profit
Highest at USD 558.1 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 33.85 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 555.1 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 460.41 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.66
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 7,899.3 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 1.24 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 7.31 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -0.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales